Literature DB >> 12019099

An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin.

Kavindra V Singh1, George M Weinstock, Barbara E Murray.   

Abstract

Enterococcus faecalis isolates are resistant to clindamycin (CLI) and quinupristin-dalfopristin (Q-D), and this is thought to be a species characteristic. Disruption of a gene (abc-23, now designated lsa, for "lincosamide and streptogramin A resistance") of E. faecalis was associated with a > or =40-fold decrease in MICs of Q-D (to 0.75 microg/ml), CLI (to 0.12 to 0.5 microg/ml), and dalfopristin (DAL) (to 4 to 8 microg/ml) for the wild-type E. faecalis parental strain (Q-D MIC, 32 microg/ml; CLI MIC, 32 to 48 microg/ml; DAL MIC, 512 microg/ml). Complementation of the disruption mutant with lsa on a shuttle plasmid resulted in restoration of the MICs of CLI, Q-D, and DAL to wild-type levels. Under high-stringency conditions, lsa was found in 180 of 180 isolates of E. faecalis but in none of 189 other enterococci. Among 19 erm(B)-lacking Enterococcus faecium strains, 9 (47%) were highly susceptible to CLI (MIC, 0.06 to 0.25 microg/ml) and had DAL MICs of 4 to 16 microg/ml; for the remaining erm(B)-lacking E. faecium strains, the CLI and DAL MICs were 4 to > 256 and 2 to > 128 microg/ml, respectively. In contrast, none of 32 erm(B)-lacking E. faecalis strains were susceptible (CLI MIC range, 16 to 32 microg/ml; DAL MIC range, > or =32 microg/ml). When lsa was introduced into an E. faecium strain initially susceptible to CLI, the MICs of CLI and DAL increased > or =60-fold and that of Q-D increased 6-fold (to 3 to 6 microg/ml). Introduction of lsa into two DAL-resistant (MICs, > 128 microg/ml), Q-D-susceptible (MICs, 0.5 and 1.5 microg/ml) E. faecium strains (CLI MICs, 12 and >256 microg/ml) resulted in an increase in the Q-D MICs from 3- to 10-fold (to 8 and >32 microg/ml), respectively. Although efflux was not studied, the similarity (41 to 64%) of the predicted Lsa protein to ABC proteins such as Vga(A), Vga(B), and Msr(A) of Staphylococcus aureus and YjcA of Lactococcus lactis and the presence of Walker A and B ATP-binding motifs suggest that this resistance may be related to efflux of these antibiotics. In conclusion, lsa appears to be an intrinsic gene of E. faecalis that explains the characteristic resistance of this species to CLI and Q-D.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019099      PMCID: PMC127256          DOI: 10.1128/AAC.46.6.1845-1850.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

Review 1.  Quinupristin-dalfopristin: an overview.

Authors:  G Delgado; M M Neuhauser; D T Bearden; L H Danziger
Journal:  Pharmacotherapy       Date:  2000-12       Impact factor: 4.705

Review 2.  Enterococcus faecalis multi-drug resistance transporters: application for antibiotic discovery.

Authors:  D R Davis; J B McAlpine; C J Pazoles; M K Talbot; E A Alder; C White; B M Jonas; B E Murray; G M Weinstock; B L Rogers
Journal:  J Mol Microbiol Biotechnol       Date:  2001-04

Review 3.  Vancomycin-resistant enterococcal infections.

Authors:  B E Murray
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

4.  Penicillin-binding protein 5 and expression of ampicillin resistance in Enterococcus faecium.

Authors:  L B Rice; L L Carias; R Hutton-Thomas; F Sifaoui; L Gutmann; S D Rudin
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

5.  Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.

Authors:  B Bozdogan; R Leclercq
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification.

Authors:  R W Duh; K V Singh; K Malathum; B E Murray
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

Review 7.  Quinupristin/dalfopristin: a therapeutic review.

Authors:  D R Allington; M P Rivey
Journal:  Clin Ther       Date:  2001-01       Impact factor: 3.393

8.  Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility.

Authors:  K V Singh; K Malathum; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403.

Authors:  A Bolotin; P Wincker; S Mauger; O Jaillon; K Malarme; J Weissenbach; S D Ehrlich; A Sorokin
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

10.  In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification.

Authors:  K V Singh; T M Coque; G M Weinstock; B E Murray
Journal:  FEMS Immunol Med Microbiol       Date:  1998-08
View more
  70 in total

1.  Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci.

Authors:  Yu-Hong Min; Jae-Hee Jeong; Yun-Jeong Choi; Hee-Jeong Yun; Kyungwon Lee; Mi-Ja Shim; Jin-Hwan Kwak; Eung-Chil Choi
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals.

Authors:  Julien Haroche; Anne Morvan; Marilyne Davi; Jeanine Allignet; François Bimet; Névine El Solh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Novel plasmid-borne multidrug resistance gene cluster including lsa(E) from a linezolid-resistant Enterococcus faecium isolate of swine origin.

Authors:  Hongbin Si; Wan-Jiang Zhang; Shengbo Chu; Xiu-Mei Wang; Lei Dai; Xin Hua; Zhimin Dong; Stefan Schwarz; Siguo Liu
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

4.  In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria.

Authors:  G M Eliopoulos; M J Ferraro; C B Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.

Authors:  Alexandre R Marra; Yvette Major; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

6.  Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycin.

Authors:  Kavindra V Singh; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins.

Authors:  Michel Dupuis; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

8.  Evidence for the clustering of antibacterial resistance phenotypes of enterococci within integrated poultry companies.

Authors:  Eve Pleydell; Lynn Rogers; Errol Kwan; Nigel French
Journal:  Microb Ecol       Date:  2010-01-15       Impact factor: 4.552

Review 9.  The Enterococcus: a Model of Adaptability to Its Environment.

Authors:  Mónica García-Solache; Louis B Rice
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

10.  Prevalence and antimicrobial resistance of enterococcus species isolated from retail meats.

Authors:  Joshua R Hayes; Linda L English; Peggy J Carter; Terry Proescholdt; Kyung Y Lee; David D Wagner; David G White
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.